Frederick Lief Ruberg, MD

Associate Professor, Medicine

Frederick Ruberg
75 E. Newton St Collamore Building

Biography

Dr. Ruberg’s clinical and research expertise is in the field of cardiac imaging including echocardiography and cardiovascular magnetic resonance imaging (CMR). Dr. Ruberg applies imaging in research designed to facilitate improved diagnosis and management of the infiltrative cardiomyopathy cardiac amyloidosis.

Other Positions

  • Associate Professor, Radiology, Boston University School of Medicine
  • Program Director, Pilot Translational & Clinical Studies Program, Clinical and Translational Science Institute, Boston University School of Medicine
  • Active Staff Privileges, Medicine, Boston Medical Center

Education

  • University of Pennsylvania School of Medicine, MD
  • Haverford College, BA

Publications

  • Published on 10/23/2018

    Maurer MS, Ruberg FL. Early Diagnosis of Cardiac Amyloidosis by Carpal Tunnel Surgery: Is it All in the Wrist? J Am Coll Cardiol. 2018 Oct 23; 72(17):2051-2053. PMID: 30336829.

    Read at: PubMed
  • Published on 10/17/2018

    Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V. Development and validation of a survival staging system incorporating BNP in patients with light chain (AL) amyloidosis. Blood. 2018 Oct 17. PMID: 30333122.

    Read at: PubMed
  • Published on 6/19/2018

    Mints YY, Doros G, Berk JL, Connors LH, Ruberg FL. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience. ESC Heart Fail. 2018 10; 5(5):772-779. PMID: 29916559.

    Read at: PubMed
  • Published on 5/1/2018

    Siddiqi OK, Sanchorawala V, Ruberg FL. Echocardiography and Survival in Light Chain Cardiac Amyloidosis: Back to Basics. Circ Cardiovasc Imaging. 2018 May; 11(5):e007826. PMID: 29752394.

    Read at: PubMed
  • Published on 3/14/2018

    Martinez-Naharro A, Kotecha T, Norrington K, Boldrini M, Rezk T, Quarta C, Treibel TA, Whelan CJ, Knight DS, Kellman P, Ruberg FL, Gillmore JD, Moon JC, Hawkins PN, Fontana M. Native T1 and Extracellular Volume in Transthyretin Amyloidosis. JACC Cardiovasc Imaging. 2018 Mar 14. PMID: 29550324.

    Read at: PubMed
  • Published on 3/8/2018

    Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V. Once AL amyloidosis: not always AL amyloidosis. Amyloid. 2018 Jun; 25(2):139-140. PMID: 29516761.

    Read at: PubMed
  • Published on 2/9/2018

    Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid. 2018 Mar; 25(1):62-67. PMID: 29424556.

    Read at: PubMed
  • Published on 2/1/2018

    Hanson JLS, Arvanitis M, Koch CM, Berk JL, Ruberg FL, Prokaeva T, Connors LH. Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin. Circ Heart Fail. 2018 Feb; 11(2):e004000. PMID: 29449366.

    Read at: PubMed
  • Published on 1/3/2018

    Maurer MS, Ruberg FL, Weinsaft JW. More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac Amyloidosis. J Card Fail. 2018 02; 24(2):87-89. PMID: 29305971.

    Read at: PubMed
  • Published on 10/20/2017

    Arvanitis M, Chan GG, Jacobson DR, Berk JL, Connors LH, Ruberg FL. Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure. Amyloid. 2017 12; 24(4):253-255. PMID: 29052438.

    Read at: PubMed

View 62 more publications: View full profile at BUMC

View all profiles